Appendix A
Health Affairs Blog Posts
The blog posts associated with the Envisioning a Transformed Clinical Trials Enterprise for 2030 virtual workshop (listed below) are available at https://www.healthaffairs.org/topic/ss170 (accessed July 1, 2021).1
- Transforming Clinical Trials: A New Vision for 2030. In this blog post, Marilyn Metcalf and Rob Weker lay out their vision for person-centered clinical trials in the year 2030 and provide an outline of how to get there.
- Driving Towards More Inclusive Clinical Trials by 2030: Action Without Strategy Is Aimless, Strategy Without Action Is Powerless. Silas Buchanan lays out a vision for a clinical trials enterprise that benefits from diversity in its participants and workforce through ongoing community engagement.
- The Future of Clinical Trials: How Will New Technologies Affect the Lives of Participants? Andy Coravos, Eric Perakslis, and Sam Roosz envision how the lives of four fictional individuals could be changed with the integration of technologies into the clinical trials enterprise.
- A Future of Trusted Clinical Trials: Communication Strategies to Encourage Trust and Transparency. Brian Southwell discusses the
___________________
1 These Health Affairs blog posts represent the opinions of the authors and do not necessarily represent the views of any one organization; the Forum on Drug Discovery, Development, and Translation; or the National Academies, and were not subjected to the review procedures of, nor are a publication or product of, the National Academies.
- importance of fostering trust and transparency in the clinical trials enterprise for improving the person-centeredness and relevance of clinical trial research.
- Clinical Trials in Crisis: Building on COVID-19’s Lessons Toward a Better Future. Esther Krofah, Steven Galson, Robert Califf, and Gregory Simon synthesize three central categories emerging from these workshop discussions for future improvement—engagement, efficiency, and coordination—and issue a call to action.